Nigeria Pharmaceuticals Market: By Product Type, By Formulation, By Therapeutic Area, By Distribution Channel and Country

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Nigeria Pharmaceuticals Market: By Product Type (Prescription Drugs, Over-the-Counter Drugs), By Formulation (Solid, Liquid, Semi-Solid), By Therapeutic Area (Infectious Diseases, Cardiovascular Diseases, Diabetes and Metabolic Disorders, Neurological Diseases, Cancer, Autoimmune Disorders, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies) and Country

checked icon checked icon arrow_drop_down
checked icon Single User License $3100 $2480
checked icon Multiple User License $4600 $3680
checked icon Corporate User License $6900 $5520

Pharmaceuticals are the drugs used to diagnose, treat, prevent, or cure the various diseases. The increase in the prevalence of infectious diseases such as Malaria (approximately 300,000 deaths occur due to malaria) and diarrhea (according to WHO, approximately 10% deaths occur due to diarrheal disease), expansion of businesses by global market players by acquiring local companies are anticipated to fuel the Nigeria pharmaceuticals market. Moreover, rise in incidence of chronic diseases such as AIDS and cancer, rapid urbanization, and rise in healthcare expenditure are expected to boost the Nigeria pharmaceuticals market over the forecast years. However, lack of R&D activities may hinder the growth of Nigeria pharmaceuticals market over forecast period.

Market Key Developments:

  • In March 2017, French pharmaceutical firm, Biogaran SAS acquired Swiss Pharma Nig Ltd for expanding its business in Nigeria

Nigeria Pharmaceuticals Market Segmentation Analysis

Report Benchmarks

Details

By Product Type

  • Prescription Drugs
  • Over-the-Counter Drugs

By Formulation

  • Solid
  • Liquid
  • Semi-Solid

By Therapeutic Area

  • Infectious Diseases
  • Malaria
  • Diarrhea
  • AIDS
  • Hepatitis
  • Tuberculosis
  • Other Infectious Diseases
  • Cardiovascular Diseases
  • Diabetes and Metabolic Disorders

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies

Key Features of the Report

  • The nigeria pharmaceuticals market report provides granular level information about the market size, regional market share, historic market (2019 to 2023) and forecast (2024 to 2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

2023 is the base year and 2030 is the forecast year.

The Nigeria Pharmaceuticals Market Key Players are Biogaran S.A.S, Fidson Healthcare PLC, GlaxoSmithKline PLC, Emzor Pharmaceutical Industries Ltd.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2. Nigeria Pharmaceuticals Market Introduction 
2.1. Nigeria Pharmaceuticals Market  - Taxonomy
2.2. Nigeria Pharmaceuticals Market  - Definitions
2.2.1.Product Type
2.2.2.Formulation
2.2.3.Therapeutic Area
2.2.4.Distribution Channel
3. Nigeria Pharmaceuticals Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Nigeria Pharmaceuticals Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Nigeria Pharmaceuticals Market  By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Prescription Drugs
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Over-the-Counter Drugs
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6. Nigeria Pharmaceuticals Market  By Formulation, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Solid
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Liquid
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Semi-Solid
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7. Nigeria Pharmaceuticals Market  By Therapeutic Area, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Infectious Diseases
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Malaria
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Diarrhea
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. AIDS
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Hepatitis
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
7.6. Tuberculosis
7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.6.3. Market Opportunity Analysis 
7.7. Other Infectious Diseases
7.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.7.3. Market Opportunity Analysis 
7.8. Cardiovascular Diseases
7.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.8.3. Market Opportunity Analysis 
7.9. Diabetes and Metabolic Disorders
7.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.9.3. Market Opportunity Analysis 
8. Nigeria Pharmaceuticals Market  By Distribution Channel, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. Hospital Pharmacies
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Retail Pharmacies
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
9. Competition Landscape
9.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
9.2.1.Biogaran S.A.S 
9.2.2.Servier laboratories
9.2.3.Fidson Healthcare PLC
9.2.4.GlaxoSmithKline PLC
9.2.5.Emzor Pharmaceutical Industries Ltd. 
9.2.6.Emzor Chemists Limited
9.2.7.May & Baker Nigeria Plc.
9.2.8.Chemiron International Limited
9.2.9.Zolon healthcare limited.
9.2.10.NEROS Pharmaceuticals Ltd.
10. Research Methodology 
11. Appendix and Abbreviations 

Key Market Players

  • Biogaran S.A.S 
  • Servier laboratories
  • Fidson Healthcare PLC
  • GlaxoSmithKline PLC
  • Emzor Pharmaceutical Industries Ltd. 
  • Emzor Chemists Limited
  • May & Baker Nigeria Plc.
  • Chemiron International Limited
  • Zolon healthcare limited.
  • NEROS Pharmaceuticals Ltd.

Related Industry Reports

Microbial Biopharmaceuticals Market

Africa Pharmaceuticals Market

Aquaculture Pharmaceuticals Market

Livestock Pharmaceuticals Market